— Know what they know.
Not Investment Advice
Also trades as: MOOD.CN (CNQ) · $vol 0M

DOSEF OTC

Doseology Sciences Inc.
1W: +0.0% 1M: +0.0% 3M: -0.6% YTD: -68.2% 1Y: -88.9% 3Y: -50.5%
$0.11
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 46 · $501357 mcap · 2M float · 0.014% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$31K -68.3% ▼
Gross Profit
$19K -73.8% ▼
Operating Income
-$346K +8.3% ▲
Net Income
-$329K +3.2% ▲
EPS (Diluted)
$-0.07 +10.7% ▲
EBITDA
-$329K -2.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$16K$43K$99K$31K
YoY Growth+0.0%+0.0%+168.5%+128.7%-68.3%
Cost of Revenue$0$164K$2K$26K$24K
Gross Profit$0-$148K$41K$72K$19K
Gross Margin—-924.6%95.8%73.2%60.4%
R&D Expenses$112K$62K$500$0$3K
SG&A Expenses$1M$1M$760K$350K$427K
Operating Expenses$2M$2M$873K$450K$490K
Operating Income-$2M-$2M-$767K-$378K-$346K
Operating Margin—-11277.5%-1780.4%-383.3%-1108.2%
Interest Expense$68K$76K$36K$0$0
Income Before Tax-$2M-$2M-$2M-$340K-$329K
Tax Expense$0$0$36K$0$0
Net Income-$2M-$2M-$2M-$340K-$329K
Net Margin—-12084.5%-4134.7%-344.9%-1052.2%
EPS (Diluted)$-0.04$-0.05$-0.04$-0.08$-0.07
EBITDA-$1M-$2M-$2M-$319K-$329K
Shares Outstanding41M39M41M4M5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms